02 Jun 2010
In this study by Shiota and colleagues, heterochromatin protein 1β (HP1β) was found to enhance the DNA-binding ability of AR. In prostate cancer tissues, silencing HP1β suppressed prostate cancer progression and may present a novel therapeutic target. Shiota, M et al (2010) Endocrine-Related Cancer 17.